Andrew Namanja

Andrew Namanja

AbbVie Inc - Chicago / United States
Medical and Health Sciences / Biochemistry
AD Scientific Index ID: 4402391
-
person_outline Andrew Namanja's MOST POPULAR ARTICLES
1-) Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenograftsX Zhang, P Yue, BDG Page, T Li, W Zhao, AT Namanja, D Paladino, ...Proceedings of the National Academy of Sciences 109 (24), 9623-9628, 20123352012
2-) Substrate recognition reduces side-chain flexibility for conserved hydrophobic residues in human Pin1AT Namanja, T Peng, JS Zintsmaster, AC Elson, MG Shakour, JW PengStructure 15 (3), 313-327, 2007962007
3-) Insights into high affinity small ubiquitin-like modifier (SUMO) recognition by SUMO-interacting motifs (SIMs) revealed by a combination of NMR and peptide array analysisAT Namanja, YJ Li, Y Su, S Wong, J Lu, LT Colson, C Wu, SSC Li, Y ChenJournal of Biological Chemistry 287 (5), 3231-3240, 2012892012
4-) Stereospecific gating of functional motions in Pin1AT Namanja, XJ Wang, B Xu, AY Mercedes-Camacho, KA Wilson, ...Proceedings of the National Academy of Sciences 108 (30), 12289-12294, 2011902011
5-) Hydroxamic Acid and Benzoic Acid–Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In VivoP Yue, F Lopez-Tapia, D Paladino, Y Li, CH Chen, AT Namanja, T Hilliard, ...Cancer research 76 (3), 652-663, 2016782016